Home
Mono Pharmacare Ltd Share Price History
Mono Pharmacare Ltd
NSE : 21 Feb, 2025
23.71.1 (4.9%)
Prev Close
22.6
Open Price
22.1
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
16000
Today's High / Low
23.7 / 22.1
52 WK High / Low
66.0 / 22.1
Market Price of Mono Pharmacare Ltd
1M
1Y
3Y
5Y
Monitoring Mono Pharmacare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2023 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 0.57 |
| YoY Gr. | - |
| Net Profit (Cr.) | 1 |
| BVPS | 10.82 |
Key Financial Parameters
| Parameter | 2023 |
|---|---|
| Return on Capital Emp. % | 3.16 |
| Op. Profit Mgn % | 6.48 |
| Net Profit Mgn % | 2.59 |
| Debt to Equity % | 3.03 |
Latest Shareholding
Promoters Holdings Over Time
About Mono Pharmacare Ltd
- Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s.
- Mono Chemist' through Partnership Deed dated May 06, 1994.
- The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad.
- The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics, Antifungal, Anti CoughCold & Anti-allergic, Antacid and Antiemetics, Analgesics and Antipyretics, Nutraceuticals, Skincare, Antiseptic, Cardiac and Diabetic & Cosmetics etc. getting products manufactured through contract manufacturing. Supal Distributors LLP, a Partnership Firm, was incorporated on November 24, 2016, with the Promoters of Company, Panilam Lakhatariya and Supal Lakhatariya, being the Original Partners.
Popular Search
FAQs for Mono Pharmacare Ltd Share Price History
What are the key events that typically impact Mono Pharmacare Ltd's share price history?
Key events that impact Mono Pharmacare Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Mono Pharmacare Ltd's share price history?
Stock splits reduce the nominal price of Mono Pharmacare Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Mono Pharmacare Ltd?
Dividends can influence Mono Pharmacare Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Mono Pharmacare Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Mono Pharmacare Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Mono Pharmacare Ltd’s share price history?
To understand Mono Pharmacare Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
